RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: MD, United States

: | OTC Markets: RGRX | OTC Markets: RGNXW

Similar to: BioGaia AB, ViroPharma, Inc., Skystar Bio-Pharmaceutical Co.

RegeneRx Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the design, research and development of novel peptides targeted at diseases with unmet medical needs. Its products are: RGN-352 Injectable, RGN-259 Eye Drops, RGN-137 Topical, RGN-457 Inhalation & Cosmeceutical Peptides. Regenerx was founded in 1982 and is headquartered in Rockville, MD.

News & Analysis

You may also be interested in: